スポンサーリンク
メジカルビュー社 | 論文
- What's going on 乳癌 Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. Berry DA, et al. JAMA. 2006; 295: 1658-67. PMID: 16609087
- What's going on 消化器癌 American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage 2 colon cancer. Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E,
- What's going on 病理 Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. Jagadeeswaran R, et al. Cancer Res. 2006; 66: 352-61. PMID: 16397249--中皮腫においてc-Metの発現が亢進し、チロシンキナーゼ阻害剤が中皮腫細胞の増殖を抑制することを示した論文
- Phase 3 trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage 3 ovarian cancer:A Gynecologic Oncology Group study(COG158).Ozols RF,et al:Gynecologic Oncology Group.J Clin Oncol 2003;21:3194-20
- What's going on 消化器癌 Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Delaunoit T, Alberts SR, Sargent DJ, Green E, Goldberg RM, Krook J, Fuchs C, Ramanathan RK, Williamson SK, Morton RF, Findlay BP. Ann On
- What's going on 頭頸部癌 Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma. Chun PY, et al. Cancer Res. 2006; 66: 981-8. PMID: 16424033--頭頸部癌におけるゲムシタビンとゲフィチニブ併用療法の相乗効果を示した論文
- HER-2 testing and trastuzumab therapy for metastatic breast cancer:a cost-effectiveness analysis.Elkin EB,et al.J Clin Oncol 2004;22:854-63.PMID:14990641--HER2陽性転移性乳癌における、HER2検査方法別のtrastuzumab療法の費用効果分析を評価した論文
- What's going on 放射線 Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. Vinh-Hung V, Verschraegen C; for The Breast Conserving Surgery Project. J Natl Cancer Inst 2004; 96
- Overview (特集 抗がん剤のDrug Delivery System)
- 頭頚部癌治療における経口フッ化ピリミジン系薬剤の役割--現状と今後の展望 (特集 経口抗癌剤治療の現状)
- What's going on 頭頸部がん(切除不能頭頸部がん)に対するシスプラチン・フルオロウラシルとシスプラチン・フルオロウラシル・ドセタキセルの比較試験[Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Ro
- 臨床試験に入ったミセル体(シスプラチン内包ミセルNC6004) (特集 抗がん剤のDrug Delivery System)
- What's going on 消化器癌 Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Fra
- ビスフォスフォネート製剤の意義 (特集 多発性骨髄腫)
- Waldenstroem型マクログロブリン血症の鑑別診断と最新治療 (特集 多発性骨髄腫)
- What's going on 乳癌 A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, et al. Cancer Cell. 2004;5:607-16. PMID:15193263--術後補助療法におけるタモキシフェンへの反応性
- Bevacizumab/Cetuximab(IMC-C225)を用いた治療法:結腸・直腸癌に対して (特集 ADCCとCDCが飛躍的に高まった抗体療法)
- What's going on 局所進行切除不能3期非小細胞肺がんに対する化学放射線同時併用療法前の導入化学療法の有効性に関する比較試験--CALGB臨床試験[Vokes EE, Herndon JE 2nd, Kelley MJ, Cicchetti MG, Ramnath N, Neill H, AtkinS JN, Watson DM, Akerley W, Green MR; Cancer and Leukemia Group B 'Induction chemotherapy followed
- A Randomized controlled trial of fluorouracil plus leucovorin,irinotecan,and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.Goldberg RM,et al.J Clin Oncol 2004;1:23-30.PMID:14665611--切除不能・再発大腸癌のfirst-line chemo
- What's going on 消化器癌 Capecitabine as adjuvant treatment for stage 3 colon cancer. Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V, Husseini F, Jodrell D, Koralewski P, Kroning H, Maroun J,
スポンサーリンク